Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis

Background: The purpose of this meta-analysis was to evaluate the controversy of angiotensin-converting enzyme inhibitor (ACEI) in combination with angiotensin-receptor blocker (ARB) in the treatment of chronic kidney disease (CKD) based on dose.Methods: PubMed, EMBASE, and Cochrane Library were sea...

Full description

Bibliographic Details
Main Authors: Mingming Zhao, Rumeng Wang, Yi Yu, Meiying Chang, Sijia Ma, Hanwen Zhang, Hua Qu, Yu Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
ACEI in combination with ARB
dose
chronic kidney disease
urine albumin excretion
urine protein excretion
glomerular filtration rate
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.638611/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.638611/full

Similar Items